Transcriptomic-Wide Discovery of Direct and Indirect HuR RNA Targets in Activated CD4(+) T Cells

por Techasintana, Patsharaporn, Davis, J. Wade, Gubin, Matthew M., Magee, Joseph D., Atasoy, Ulus
Publicado 2015

Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip

por Dahm, Garrett M., Gubin, Matthew M., Magee, Joseph D., Techasintana, Patsharaporn, Calaluce, Robert, Atasoy, Ulus
Publicado 2012

The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer

por Calaluce, Robert, Gubin, Matthew M, Davis, J Wade, Magee, Joseph D, Chen, Jing, Kuwano, Yuki, Gorospe, Myriam, Atasoy, Ulus
Publicado 2010

BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy

por Salmon, Avery J., Shavkunov, Alexander S., Miao, Qi, Jarjour, Nicholas N., Keshari, Sunita, Esaulova, Ekaterina, Williams, Charmelle D., Ward, Jeffrey P., Highsmith, Anna M., Pineda, Josué E., Taneja, Reshma, Chen, Ken, Edelson, Brian T., Gubin, Matthew M.
Publicado 2022

The RNA-Binding Protein HuR Posttranscriptionally Regulates IL-2 Homeostasis and CD4(+) Th2 Differentiation

por Techasintana, Patsharaporn, Ellis, Jason S., Glascock, Jacqueline, Gubin, Matthew M., Ridenhour, Suzanne E., Magee, Joseph D., Hart, Marcia L., Yao, Peng, Zhou, Hao, Whitney, Maryln S., Franklin, Craig L., Martindale, Jennifer L., Gorospe, Myriam, Davis, Wade J., Fox, Paul L., Li, Xiaoxia, Atasoy, Ulus
Publicado 2017

MHC-II neoantigens shape tumor immunity and response to immunotherapy

por Alspach, Elise, Lussier, Danielle M., Miceli, Alexander P., Kizhvatov, Ilya, DuPage, Michel, Luoma, Adrienne M., Meng, Wei, Lichti, Cheryl F., Esaulova, Ekaterina, Vomund, Anthony N., Runci, Daniele, Ward, Jeffrey P., Gubin, Matthew M., Medrano, Ruan F.V., Arthur, Cora D., White, J. Michael, Sheehan, Kathleen C.F., Chen, Alex, Wucherpfennig, Kai W., Jacks, Tyler, Unanue, Emil R., Artyomov, Maxim N., Schreiber, Robert D.
Publicado 2019

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

por Gubin, Matthew M., Zhang, Xiuli, Schuster, Heiko, Caron, Etienne, Ward, Jeffrey P., Noguchi, Takuro, Ivanova, Yulia, Hundal, Jasreet, Arthur, Cora D., Krebber, Willem-Jan, Mulder, Gwenn E., Toebes, Mireille, Vesely, Matthew D., Lam, Samuel S.K., Korman, Alan J., Allison, James P., Freeman, Gordon J., Sharpe, Arlene H., Pearce, Erika L., Schumacher, Ton N., Aebersold, Ruedi, Rammensee, Hans-Georg, Melief, Cornelis J. M., Mardis, Elaine R., Gillanders, William E., Artyomov, Maxim N., Schreiber, Robert D.
Publicado 2014

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

por Zhou, Yifan, Medik, Yusra B., Patel, Bhakti, Zamler, Daniel B., Chen, Sijie, Chapman, Thomas, Schneider, Sarah, Park, Elizabeth M., Babcock, Rachel L., Chrisikos, Taylor T., Kahn, Laura M., Dyevoich, Allison M., Pineda, Josue E., Wong, Matthew C., Mishra, Aditya K., Cass, Samuel H., Cogdill, Alexandria P., Johnson, Daniel H., Johnson, Sarah B., Wani, Khalida, Ledesma, Debora A., Hudgens, Courtney W., Wang, Jingjing, Wadud Khan, Md Abdul, Peterson, Christine B., Joon, Aron Y., Peng, Weiyi, Li, Haiyan S., Arora, Reetakshi, Tang, Ximing, Raso, Maria Gabriela, Zhang, Xuegong, Foo, Wai Chin, Tetzlaff, Michael T., Diehl, Gretchen E., Clise-Dwyer, Karen, Whitley, Elizabeth M., Gubin, Matthew M., Allison, James P., Hwu, Patrick, Ajami, Nadim J., Diab, Adi, Wargo, Jennifer A., Watowich, Stephanie S.
Publicado 2022